This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Caliper Completes CBD Pharmacokinetic Research in Partnership with Colorado State University
Research found Caliper products offer faster absorption times than controls.
Caliper Foods, in conjunction with Colorado State University (CSU), has completed a clinical study of commercially available CBD-infused food and supplement product pharmacokinetics.
This study was approved by an Institutional Review Board (IRB) in compliance with the requirements of 45 CFR 46 for human clinical research.